Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Preliminary Clinical Study on the Safety and Efficacy of the Gene Replacement Drug ZVS106e in the Treatment of Hereditary Retinal Degeneration (IRDs) Caused by ABCA4 Biallelic Mutations

NCT07241169 is registered in ClinicalTrials.gov with Zhongshan Ophthalmic Center, Sun Yat-sen University as lead sponsor.

NCT NCT07241169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07241169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Preliminary Clinical Study on the Safety and Efficacy of the Gene Replacement Drug ZVS106e in the Treatment of Hereditary Retinal Degeneration (IRDs) Caused by ABCA4 Biallelic Mutations
Lead sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University
Phase
Phase 1
Overall status
Recruiting
Start date
December 29, 2025
Completion date
December 30, 2028
Enrollment
9 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

stargardt